NewslettersImmunology of Infectious Disease NewsA Highly Immunogenic Vaccine Platform Against Encapsulated Pathogens Using Chimeric Probiotic Escherichia coli Membrane VesiclesBy Laurisa Dohm - November 30, 20220184The authors constructed a probiotic E. coli clone harboring the genetic locus responsible for biogenesis of serotype 14 pneumococcal capsular polysaccharides as a model antigen.[NPJ Vaccines]Full Article